James S L, Correa-Oliveira R, Leonard E J
J Immunol. 1984 Sep;133(3):1587-93.
Cellular immune responses against larval and adult schistosome antigens were studied in attenuated cercariae-vaccinated P and C57BL/6 mice to define differences correlating with the inability of P mice to develop vaccine-induced resistance to challenge Schistosoma mansoni infection. Vaccinated P mice failed to demonstrate delayed hypersensitivity upon skin-testing with soluble worm antigens, whereas mice of the highly resistant strain C57BL/6 developed a significant 24-hr response to worm antigens in vivo. Also, when schistosome antigens were injected i.p., vaccinated P mice failed to exhibit an activated macrophage response in vivo, whereas vaccinated C57BL/6 mice developed macrophages with significant larvicidal and tumoricidal activity at the site of specific antigen challenge. Immune sera from either vaccinated C57BL/6 or P mice were equally effective at opsonizing the schistosomula targets in the larvicidal assay. In vitro analyses of cellular defects revealed that although T lymphocytes from vaccinated P mice showed blastogenic responses to schistosome antigens that were similar in magnitude and kinetics to those of cells from the C57BL/6 animals, T cells from C57BL/6 mice produced higher levels of macrophage-activating lymphokines (LK), including gamma-interferon. Macrophages from control C57BL/6 mice were also more responsive to activation by LK than macrophages from P mice were, as assessed by stimulation of these cells to kill skin-stage schistosomula in vitro. These two aspects of cellular dysfunction in P mice had the combined effect of rendering P macrophages incapable of activation by LK from mice of their own strain, whereas macrophages from C57BL/6 mice were strongly activated by LK from vaccinated C57BL/6 mice in the same assays. Thus, a correlation exists between T lymphocyte/macrophage dysfunction and lack of resistance to challenge infection in vaccinated P mice, which suggests that delayed hypersensitivity response plays a major role in the immunity to S. mansoni infection that is induced by exposure to radiation-attenuated cercariae.
在减毒尾蚴疫苗接种的P小鼠和C57BL/6小鼠中研究了针对幼虫和成虫血吸虫抗原的细胞免疫反应,以确定与P小鼠无法产生疫苗诱导的对曼氏血吸虫攻击感染的抵抗力相关的差异。接种疫苗的P小鼠在用可溶性虫抗原进行皮肤试验时未表现出迟发型超敏反应,而高度抗性的C57BL/6品系小鼠在体内对虫抗原产生了显著的24小时反应。此外,当腹腔注射血吸虫抗原时,接种疫苗的P小鼠在体内未表现出活化的巨噬细胞反应,而接种疫苗的C57BL/6小鼠在特异性抗原攻击部位产生了具有显著杀幼虫和杀肿瘤活性的巨噬细胞。来自接种疫苗的C57BL/6或P小鼠的免疫血清在杀幼虫试验中对血吸虫毛蚴靶标的调理作用同样有效。细胞缺陷的体外分析表明,尽管来自接种疫苗的P小鼠的T淋巴细胞对血吸虫抗原的增殖反应在幅度和动力学上与来自C57BL/6动物的细胞相似,但来自C57BL/6小鼠的T细胞产生了更高水平的巨噬细胞活化淋巴因子(LK),包括γ干扰素。通过体外刺激这些细胞杀死皮肤期血吸虫毛蚴评估,对照C57BL/6小鼠的巨噬细胞对LK激活的反应也比P小鼠的巨噬细胞更敏感。P小鼠细胞功能障碍的这两个方面共同导致P巨噬细胞无法被来自其自身品系小鼠的LK激活,而在相同试验中,来自C57BL/6小鼠的巨噬细胞被来自接种疫苗的C57BL/6小鼠的LK强烈激活。因此,接种疫苗的P小鼠中T淋巴细胞/巨噬细胞功能障碍与对攻击感染缺乏抵抗力之间存在相关性,这表明迟发型超敏反应在由暴露于辐射减毒尾蚴诱导的对曼氏血吸虫感染的免疫中起主要作用。